1 year return (CAGR)
-25.05%
Grifols SA ADR Exchange (NASDAQ, USD)
GRFS
7.36
+0.05 (+0.68%)
HealthcareDrug Manufacturers - General
Loading...
3 year return (CAGR)
-9.29%
5 year return (CAGR)
-12.46%
10 year return (CAGR)
-7.65%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.90B
Price/Sales
0.26
Ent value
13.50B
Price/Book
0.24
Div yield
12.41%
Growth years
-
Div growth
-
FCF payout
14.82%
Trailing P/E
4.20
PEG
-
Forward P/E
5.16
EPS growth
-8.86%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.34 |
| Daily high | 7.39 |
| Daily low | 7.33 |
| Daily Volume | 357K |
| All-time high | 25.63 |
| 1y analyst estimate | 10.87 |
| Beta | 1.19 |
| EPS (TTM) | 0.66 |
| Dividend per share | 0.91 |
| Ex-div date | 2 Jul 2026 |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GRFS | S&P500 | |
| Current price drop from All-time high | -71.28% | -0.56% |
| Highest price drop | -78.66% | -56.47% |
| Date of highest drop | 6 Mar 2024 | 9 Mar 2009 |
| Avg drop from high | -33.58% | -10.68% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 1654 days | 1805 days |
News
Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy (Rating Upgrade)
Grifols successfully refinanced all 2027 debt maturities ahead of schedule, extending maturities and lowering funding costs. Read more on GRFS stock here.
July 3, 2026